NCT07162896View on ClinicalTrials.gov

Crisaborole 2% Versus Tacrolimus 0.1% in Children With Mild to Moderate Atopic Dermatitis

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

June 30, 2026

Primary Completion Date

January 31, 2027

Study Completion Date

June 30, 2027

Conditions
Atopic DermatitisAtopic Dermatitis (AD)
Interventions
DRUG

Crisaborole 2%

Apply thin layer to affected skin daily for 28 days.

DRUG

Tacrolimus 0.1%

Apply thin layer to affected skin daily for 28 days.

Trial Locations (1)

54000

Shalamar Hospital Lahore, Lahore

All Listed Sponsors
lead

Shalamar Institute of Health Sciences

OTHER